Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial.
Belani CP, Pereira JR, von Pawel J, Pluzanska A, Gorbounova V, Kaukel E, Mattson KV, Ramlau R, Szczesna A, Fidias P, Millward M, Fossella F; TAX 326 study group. Belani CP, et al. Among authors: szczesna a. Lung Cancer. 2006 Aug;53(2):231-9. doi: 10.1016/j.lungcan.2006.05.003. Epub 2006 Jun 19. Lung Cancer. 2006. PMID: 16787687 Clinical Trial.
Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group.
Fossella F, Pereira JR, von Pawel J, Pluzanska A, Gorbounova V, Kaukel E, Mattson KV, Ramlau R, Szczesna A, Fidias P, Millward M, Belani CP. Fossella F, et al. Among authors: szczesna a. J Clin Oncol. 2003 Aug 15;21(16):3016-24. doi: 10.1200/JCO.2003.12.046. Epub 2003 Jul 1. J Clin Oncol. 2003. PMID: 12837811 Clinical Trial.
Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial.
Gatzemeier U, Pluzanska A, Szczesna A, Kaukel E, Roubec J, De Rosa F, Milanowski J, Karnicka-Mlodkowski H, Pesek M, Serwatowski P, Ramlau R, Janaskova T, Vansteenkiste J, Strausz J, Manikhas GM, Von Pawel J. Gatzemeier U, et al. Among authors: szczesna a. J Clin Oncol. 2007 Apr 20;25(12):1545-52. doi: 10.1200/JCO.2005.05.1474. J Clin Oncol. 2007. PMID: 17442998 Clinical Trial.
Cisplatin-based three drugs combination (NIP) as induction and adjuvant treatment in locally advanced non-small cell lung cancer: final results.
Gottfried M, Ramlau R, Krzakowski M, Ziolo G, Olechnowicz H, Koubkova L, Dahabreh J, Szczesna A, Vivanco GL, Perng RP, Carpagnano F, Leong SS, Fittipaldo A, De Almeida C, Aubert D, Grunenwald D. Gottfried M, et al. Among authors: szczesna a. J Thorac Oncol. 2008 Feb;3(2):152-7. doi: 10.1097/JTO.0b013e318160c0e7. J Thorac Oncol. 2008. PMID: 18303436 Free article. Clinical Trial.
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.
Pirker R, Pereira JR, Szczesna A, von Pawel J, Krzakowski M, Ramlau R, Vynnychenko I, Park K, Yu CT, Ganul V, Roh JK, Bajetta E, O'Byrne K, de Marinis F, Eberhardt W, Goddemeier T, Emig M, Gatzemeier U; FLEX Study Team. Pirker R, et al. Among authors: szczesna a. Lancet. 2009 May 2;373(9674):1525-31. doi: 10.1016/S0140-6736(09)60569-9. Lancet. 2009. PMID: 19410716 Clinical Trial.
Phase III trial comparing vinflunine with docetaxel in second-line advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy.
Krzakowski M, Ramlau R, Jassem J, Szczesna A, Zatloukal P, Von Pawel J, Sun X, Bennouna J, Santoro A, Biesma B, Delgado FM, Salhi Y, Vaissiere N, Hansen O, Tan EH, Quoix E, Garrido P, Douillard JY. Krzakowski M, et al. Among authors: szczesna a. J Clin Oncol. 2010 May 1;28(13):2167-73. doi: 10.1200/JCO.2009.23.4146. Epub 2010 Mar 29. J Clin Oncol. 2010. PMID: 20351334 Clinical Trial.
Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non-small-cell lung cancer: a phase III trial.
Scagliotti GV, Krzakowski M, Szczesna A, Strausz J, Makhson A, Reck M, Wierzbicki RF, Albert I, Thomas M, Miziara JE, Papai ZS, Karaseva N, Thongprasert S, Portulas ED, von Pawel J, Zhang K, Selaru P, Tye L, Chao RC, Govindan R. Scagliotti GV, et al. Among authors: szczesna a. J Clin Oncol. 2012 Jun 10;30(17):2070-8. doi: 10.1200/JCO.2011.39.2993. Epub 2012 May 7. J Clin Oncol. 2012. PMID: 22564989 Clinical Trial.
The analysis of ALK gene rearrangement by fluorescence in situ hybridization in non-small cell lung cancer patients.
Wojas-Krawczyk K, Krawczyk PA, Ramlau RA, Szumiło J, Kozielski J, Kalinka-Warzocha E, Bryl M, Knopik-Dąbrowicz A, Spychalski L, Szczęsna A, Rydzik E, Milanowski J. Wojas-Krawczyk K, et al. Among authors: szczesna a. Contemp Oncol (Pozn). 2013;17(6):484-92. doi: 10.5114/wo.2013.38758. Epub 2013 Dec 19. Contemp Oncol (Pozn). 2013. PMID: 24592134 Free PMC article.
86 results